The recent outbreaks of human coronaviruses: A medicinal chemistry perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

Published:2020-08-27 Issue:1 Volume:41 Page:72-135
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Medicinal Research Reviews

Author:

Pillaiyar Thanigaimalai¹^ORCID,Wendt Lukas L.¹,Manickam Manoj²,Easwaran Maheswaran³^ORCID

Affiliation:

1. PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry University of Bonn Bonn Germany

2. Department of Chemistry PSG Institute of Technology and Applied Research Coimbatore Tamil Nadu India

3. Department of Biomedical Engineering Sethu Institute of Technology Virudhunagar Tamilnadu India

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21724

Reference262 articles.

1. Recent discovery and development of inhibitors targeting coronaviruses

2. An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

3. Middle East respiratory syndrome‐coronavirus (MERS‐CoV): an updated overview and pharmacotherapeutics;Pillaiyar T;Med Chem,2015

4. Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-assisted combination drug delivery: a progressive approach for the treatment of acute myeloid leukemia;Therapeutic Delivery;2024-09-13

2. Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement;Bioorganic & Medicinal Chemistry;2024-02

3. Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity;ACS Pharmacology & Translational Science;2024-01-19

4. Deciphering the SARS-CoV-2 Delta Variant: Antiviral Compound Efficacy by Molecular Docking, ADMET, and Dynamics Studies;MOROC J CHEM;2024

5. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study;Journal of Clinical Medicine;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3